Search Results 2531-2540 of 40721 for Two-phase

1. Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   During the early phases (phases 1 and 2), researchers assess safety, side ... Phase 1: any DLBCL subtype. Phase 2: activated B-cell or unclassifiable ...

4. When might a mole mean cancer? - Mayo Clinic News Network

   Monitoring moles and other pigmented patches is an important step in detecting skin cancer, especially malignant melanoma. Symptoms. The typical mole is a brown ...

5. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

6. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

7. Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer - Mayo Clinic

   About this study. This is a multicenter, open-label, Phase 1, dose escalation trial to evaluate the safety, tolerability, and recommended Phase 2 dose ...

8. A Study To Evaluate Safety Of Long-term AL001 Dosing In FTD Patients - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. A Study to Evaluate the Effectiveness and Safety of DA-1229 (Evogliptin) in Delaying Progression of Mild or Moderate Calcific Aortic Stenosis (EVOID-AS trial) - Mayo Clinic

   The study will have three phases: Screening Period (up to 4 weeks), Treatment Period (104 weeks), and Follow-Up Period (2-4 weeks). Total Study Duration is 112 ...

10. Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma - Mayo Clinic

    Overview. Tab Title Description. Study typeInterventional Study phase2. Study ... two lines of chemotherapy, without a formal statistical comparison between the ...